R & D Center
Introduction of provincial R & D Center
Zhejiang Jingjia Medical Technology Co., Ltd. specializes in the field of medical sodium hyaluronate gels, and products involve Surgical Adhesion Formation, Ophthalmic Viscoelastics, joint lubrication and minimally invasive plastic filling, etc.The company attaches great importance to the research and development of new technologies and new products. Since establishment in 1995, we has been committed to the research and development of sodium hyaluronate technology and products,including the preparation of sodium hyaluronate raw materials. Through the efforts of the company's older generation of researchers, we has successfully developed the technology of extracting sodium hyaluronate injection grade raw materials from chicken combs , and applied to anti-adhesion after surgery, ophthalmic viscoelastic agent, joint injection and other fields,.The technology has the characteristics of definite curative effect, stable quality and low adverse reaction rate, then we has become one of the earliest domestic manufacturers to develop medical sodium hyaluronate . In the 21st century, with the rise of sodium hyaluronate cross-linking technology overseas, it has broadened the application of sodium hyaluronate in the medical field, such as injection microplasty, ophthalmology, urology, gynecology, etc. Jingjia Medical carried out research on sodium hyaluronate cross-linking technology earlier in China. In 2005, we introduced the research results of Peking University and developed the first plastic surgery for skin filling on the basis of digestion and absorption related results. Cross-linked sodium hyaluronate gel, after several trials, finally completed the development of industrial production technology, the quality of the prepared products is stable, the filling effect is good, the maintenance time is long, and the rate of adverse reactions is low. We entered the clinical trial stage in 2006. The results show that the company developed cross-linked sodium hyaluronate gel for plastic surgery can meet the clinical needs. In 2008, we obtained the EU CE certification, and the products were sold in 40 countries and regions around the world. In order to increase scientific research efforts and improve technological innovation capabilities, in November 2014, Zhejiang Jingjia officially established a medical sodium hyaluronate cross-linking technology research and development center, which accelerated the investment of research and development funds, the purchase of equipment and the introduction of research and development personnel. Deep-rooted work and intensive research. In June 2016, the R & D center was awarded the "Medical Sodium Hyaluronate Cross-linking R & D Center in Hangzhou". In November 2018, Jingjia was awarded the "Provincial Research and Development Center for Sodium Hyaluronate Crosslinking Technology" in Zhejiang Province, providing a solid guarantee for improving the company's product development and technological innovation capabilities.In the development process of the R & D center, the company attaches importance to system construction on the one hand, and on the other hand enhances intellectual property management. We has successively formulated and implemented regulations such as "R & D project management system", "R & D project reward system", "R & D personnel training system", etc. Efficient operation of the system. In recent years, it has obtained 1 US invention patent and 15 domestic invention patents, and 12 invention patents have obtained acceptance notices. In addition to the research and development of cross-linking technology, Zhejiang Jingjia R & D Center also conducts research on the clinical application of sodium hyaluronate, and cooperates with some well-known medical institutions such as Zhejiang Hospital, Shao Yifu Hospital, Shanghai Ninth people’s Hospital, etc. to develop new technologies and products of hyaluronic acid. 1. The research on new applications has achieved initial results. At the same time, communicate with Zhejiang University, Zhejiang Academy of Medical Sciences, Zhejiang University of Technology, etc., on the basis of a good cooperative relationship, make full use of the research and development capabilities of scientific research institutions, help the company solve some difficult problems of technological breakthroughs, and accelerate the development of the project .In the next three years, the R & D center plans to invest more than 30 million yuan for the construction of the center ’s hardware facilities, team building, and research projects, to form a team of about 60 people in the R & D center, and to cultivate a batch of HA medical application process research and quality standard research. , Technical personnel in pilot tests, product registration, clinical research, intellectual property rights, etc., provide strong intellectual support for the company to continuously develop new products and expand new channels.